Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 73,832 shares at $20.22 ($1.5M) on 2025-01-06, disclosed to the SEC on 2025-01-08.
Seasonal sale ($1.5M) by President and CEO — this insider has traded DNLI in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.22 | 29,266 | $592K | 39.4% |
| 2 | $20.22 | 29,266 | $592K | 39.4% |
| 3 | $20.81 | 7,650 | $159K | 10.6% |
| 4 | $20.81 | 7,650 | $159K | 10.6% |
| Total | $20.34 avg | 73,832 | $1.5M | 100% |
| Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $332K | — | Filing → |